Running Stocks: AEGON N.V. (NYSE:AEG), Suburban Propane Partners, L.P. (NYSE:SPH), Editas Medicine (NASDAQ:EDIT), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Ormat Technologies Inc. (NYSE:ORA) shares advanced 1.02% in last trading session and ended the day at $40.49. ORA Gross Margin is 36.70% and its has a return on assets of 5.30%. Ormat Technologies Inc. (NYSE:ORA) quarterly performance is 14.41%.

Ormat Technologies Inc. (NYSE:ORA) announced a cash dividend payment of $0.31 per share is scheduled to be paid on March 29, 2016. Shareholders who purchased ORA prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 416.67% increase over the prior quarter.

AEGON N.V. (NYSE:AEG) ended the last trading day at $5.50. Company weekly volatility is calculated as 1.72% and price to cash ratio as 1.11. AEGON N.V. (NYSE:AEG) showed a weekly performance of 1.85%.

AEGON N.V. (NYSE:AEG) has revealed it paid 98 per cent of all life claims made in 2015 to 646 families, with an average pay out of £83,000.

On 10 March, Suburban Propane Partners, L.P. (NYSE:SPH) shares decreased -1.86% and was closed at $29.53. SPH EPS growth in last 5 year was -15.70%. Suburban Propane Partners, L.P. (NYSE:SPH) year to date (YTD) performance is 25.64%.

On 3 March, Suburban Propane Partners, L.P. (NYSE:SPH) announced the refinancing of the senior secured credit facility (the “Revolving Credit Facility”) of its operating partnership, Suburban Propane, L.P. The new five-year Revolving Credit Facility amends and restates the previous revolving credit facility dated January 5, 2012 to, among other things: (i) extend the maturity date from January 5, 2017 through March 3, 2021; (ii) reduce the borrowing rate; (iii) amend certain affirmative and negative covenants and (iv) increase the revolving credit commitments thereunder from $400 million to $500 million.

Editas Medicine Inc. (NASDAQ:EDIT) shares decreased -14.02% in last trading session and ended the day at $26.74. EDIT has a return on assets of -125.70%.

Editas Medicine Inc. (NASDAQ:EDIT) announced that it presented a company overview at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8, 2016 at 8:40 a.m. ET.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) caters to the Healthcare space. It has a net profit margin of -53.90% and weekly performance is -8.02%. On the last day of trading company shares ended up at $82.28. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) distance from 50-day simple moving average (SMA50) is 2.49%.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)‘s stock had its “outperform” rating restated by stock analysts at Leerink Swann in a report issued on Tuesday, MarketBeatreports. They presently have a $128.00 target price on the pharmaceutical company’s stock, down from their prior target price of $131.00.